-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Agile Therapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from 2012 to 2023.
- Agile Therapeutics Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.75M, a 46.4% increase year-over-year.
- Agile Therapeutics Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$13.6M, a 63.8% increase year-over-year.
- Agile Therapeutics Inc annual Operating Income (Loss) for 2023 was -$19.9M, a 62.2% increase from 2022.
- Agile Therapeutics Inc annual Operating Income (Loss) for 2022 was -$52.6M, a 26% increase from 2021.
- Agile Therapeutics Inc annual Operating Income (Loss) for 2021 was -$71M, a 44.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)